Page 1070 - Markets News

Gland Pharma surges 11% amidst stellar Q4 results; profits grow two fold

On Wednesday, Gland Pharma reported a two fold jump or 145 per cent increase in consolidated net profit, reaching Rs 192.4 crore for the January-March period of FY24

Concor, Dixon: Trading strategies for stocks with high long buildup in F&O

F&O stock update for May expiry: Page Industries, Concor, Dixon, Metropolis, Crompton Greaves and Zydus Life have seen notable long buildup in recent days. Here's a short-term outlook on the stocks.

Several key Asian share benchmarks fall on patient approach to rate cuts

MSCI's broadest index of Asia-Pacific shares outside Japan lost 0.57 per cent. Australia's S&P/ASX 200 index was one of the biggest decliners

India needs 'balancing act' to manage bond index capital flows, says S&P

The index inclusion is expected to attract $40 billion in inflows in 18 months, according to estimates from Goldman Sachs Group Inc. and others

Oil to trade rangebound amid lack of bullish triggers; check key MCX levels

Brent crude oil outlook: Brokerage firm Sharekhan expects prices to trade in a broader range of $75-$80/b unless there is any major changes in terms of macroeconomics or geo-politics

High-speed traders piling into big short on volatility in Indian market

Volatility in Indian equities has been subdued over the past year, compared to US and Hong Kong stocks, but traders are bracing for potential swings around parliamentary election results

Is it time to sell auto stocks and buy IT counters? What charts say

The Nifty IT Index is currently priced at 33,613.05, indicating a bullish trend in the near term. Given this upward momentum, the best trading strategy for traders would be to buy the index either at

Jubilant FoodWorks, Nykaa, Oil India among seven stocks to track on May 23

At 6:53 AM, GIFT Nifty futures were trading down 13 points at 22,644.50 against Nifty futures

Stock market guide for May 23: Nifty F&O expiry, Nvidia, ITC, IndiGo Q4

All you need to know before the market opens on Thursday: Gift Nifty hints tepid start; IT stocks likely to be in focus post Nvidia earnings; ITC, IndiGo also to report March quarter results today.

Warburg Pincus exits Apollo Tyres; pares entire stake for Rs 1,073 crore

The American private equity major sold 22.47 million shares at Rs 477 apiece to mop up Rs 1,073 crore

Sensex rises 267 pts, Nifty gains for 5th day on buying in RIL, Infosys

Among the Sensex firms, Hindustan Unilever, Reliance Industries, Infosys, Asian Paints, ITC and UltraTech Cement were the major gainers

BHEL shares tank 8% after Q4 results miss street expectations

The fall came after the company announced its Q4 results, which missed street expectations

Higher output, reasonable valuations positive for upstream major ONGC

The upside in production volumes coupled to reasonable valuations are two reasons why most analysts are bullish on the stock

India's market capitalisation to GDP ratio at 15-year high of 140%

According to data from BSE, the 4,357 companies available for trade had a combined market capitalisation of around Rs 416 trillion on Tuesday against India's GDP at current price of Rs 296.6 trillion

Bluechips drive India past $5 trillion market capitalisation milestone

63% of mcap growth contributed by top 100 firms

Promoter of Granules India sells 3.09% stake for Rs 304 cr via open market

According to the block deal data available on the NSE, Krishna Prasad Chigurupati offloaded 75 lakh shares, amounting to a 3.09 per cent stake in Granules India

Sebi's new guidelines on mkt rumour to help in fair pricing of M&A: Experts

Market rumours pertaining to a company's business can create significant volatility in stock prices, often leading to transactions that don't reflect a company's true value

Strides rallies 9% intraday, hits over 3 year high on healthy Q4 results

Strides Pharma stock price: For FY25, Strides said revenue may grow at 12-15 per cent Y-o-Y and the significant growth will come in H2FY25 based on targeted product launches globally

Stock Market Highlights, May 22: Sensex up 268pts, Nifty near 22600; Awfis Space IPO subscribed 1.5x

Stock Market Highlights on Wednesday, May 22, 2024: M-cap of all BSE listed companies settled at Rs 416 trillion or $5 trillion today

Cipla rallies 4% on US FDA approval to market Lanreotide injection

The approval for the generic version of Lanreotide Acetate is in line with Cipla's growth strategy in the complex product segment and will strengthen Cipla's position in the US market.